Global Hyaluronic Acid in Healthcare Market to Reach $10.5 Billion by 2030

“A Comprehensive Analysis of Hyaluronic Acid’s Expanding Applications in Clinical Practice, Highlighting Innovations in Viscosupplementation, Aesthetic Medicine, and the Growing Competition from Alternative Therapies”

Boston, Nov. 20, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Hyaluronic Acid in Healthcare: Global Markets” is projected to grow from $8 billion in 2025 to $10.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2030.

This report provides a comprehensive analysis of the global market for hyaluronic acid (HA) medical products, focusing on prescription products used by healthcare professionals. It covers a range of HA applications, including dermal fillers, viscosupplements, dry eye treatments, ophthalmic viscoelastic devices, regenerative wound care, musculoskeletal repair, anti-adhesion barriers, and urology bulking agents. The report analyzes market revenue, major trends, challenges, and opportunities, and recent developments such as new products, acquisitions, and collaborations. It also examines environmental, social, and governance (ESG) factors and concludes with a competitive analysis, ranking leading companies by market share and providing company profiles.

This report is especially relevant now because hyaluronic acid’s clinical applications are rapidly expanding beyond traditional uses in aesthetics and osteoarthritis. There is significant R&D activity in areas like women’s reproductive health and regenerative medicine. At the same time, the industry is experiencing a shift toward more sustainable production methods, such as enzyme-based HA, while facing growing competition from alternative biomaterials. These trends are reshaping the competitive landscape, making it crucial for stakeholders to stay informed and adapt to ongoing changes.

The factors driving the market’s growth include:

Expanding Clinical Applications of Hyaluronic Acid: Hyaluronic acid is being adopted in a growing range of medical fields, including orthopedics, ophthalmology, dermatology and wound care. As research uncovers new therapeutic benefits, healthcare providers are using HA for more conditions.

Innovations and Biotechnology Advances: Advances in biotechnology have led to the development of safer, more effective, and specialized forms of hyaluronic acid. New production methods, improved formulations, and innovative delivery systems are making HA products more accessible and tailored to specific medical needs, further driving their use in healthcare.

Trend Toward Minimally Invasive Procedures: There is a strong shift in healthcare toward treatments that are less invasive, offering quicker recovery and fewer risks. Hyaluronic acid fits well with this trend, as it is commonly used in injectable therapies and topical applications.

Request a sample copy of the global market for hyaluronic acid medical products report.

Report Synopsis

Interesting facts:

• In the U.S. injectable aesthetics market, more than 90% of products sold are imported from the European Union, the U.K., and South Korea.

• Because of its natural tendency to bind to certain overexpressed receptors in many inflammatory and tumor settings, HA enables highly specific targeted delivery.

• HA is becoming more popular in 3D bioprinting as a bioink, allowing researchers to print living structures such as skin, blood vessels, and early organoids that mimic the architecture and biological functions of native tissues.

Emerging startups:

• Evolus Inc.: A recent entrant in the HA dermal filler space, Evolysse distinguishes itself with the FDA-approved Cold-X technology, which preserves HA structure during manufacturing. It is rapidly gaining attention for providing refined aesthetic outcomes with minimal residual swelling.

• BioRegen Biomedical (Changzhou) Co. Ltd.: BioRegen develops novel biomedical materials for wound repair as well as drug-sustained release agents. Its mission is to solve medical difficulties in the specialties of otolaryngology, gynecology and general surgery.

The report addresses the following questions:

1. What are the projected size and growth rate of the market for hyaluronic acid medical products?

• The global market was estimated at $7.6 billion in 2024 and is projected to reach $10.5 billion by the end of 2030, growing at a CAGR of 5.7% during the forecast period.

2. Which market segments are covered in the report?

• The global market for hyaluronic acid medical products, is segmented by product type, HA source type, and region.

3. Which product type will be dominant through 2030?

• Dermal fillers are anticipated to be the largest market by the end of 2030.

4. Which product type market is growing the fastest?

• Regenerative and anti-adhesion products are the fastest growing segment.

Market leaders include:

• ABBVIE INC.
• ANIKA THERAPEUTICS INC.
• BIOVENTUS
• FERRING B.V.
• FIDIA FARMACEUTICI S.P.A.
• GALDERMA
• IBSA INSTITUT BIOCHIMIQUE SA
• MEDYTOX
• MERZ PHARMA
• NORDIC PHARMA
• SANOFI
• SANTEN PHARMACEUTICAL CO. LTD.
• SEIKAGAKU CORP.
• TEOXANE
• URSAPHARM ARZNEIMITTEL GMBH

Related reports:

Medical Aesthetic Devices: Technologies and Global Markets: This report provides a comprehensive analysis of the global market for medical aesthetic devices, segmented by device type, application, end user, and region. It highlights the trends, challenges, and opportunities shaping the industry, while also offering forecasts through 2029. The report examines technological advances and emerging innovations, and covers the regional markets of North America, Europe, Asia-Pacific, and the Rest of the World. Additionally, it profiles major industry players such as Alma Lasers, Johnson & Johnson, and Allergan Aesthetics, evaluating their financial performance, product portfolios, and strategic initiatives.

Purchase a copy of the report direct from BCC Research.

For further information on any of these reports or to make a purchase, contact info@bccresearch.com.    

About BCC Research

BCC Research market research reports provide objective, unbiased measurement, and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype.

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

BCC Research

Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, U.S.
Email: info@bccresearch.com
Phone: +1 781-489-7301

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.